BLUEMED is the research and innovation Initiative for promoting the blue economy in the Mediterranean Basin through cooperation. It is the strategy of reference for the Mediterranean countries to work together for a healthy, safe and productive Mediterranean Sea. The BLUEMED Initiative will contribute to the creation of new ‘blue’ jobs, social well being and a sustainable growth in the marine and maritime sectors through the implementation of its Strategic Research and Innovation Agenda, the BLUEMED SRIA.
The BLUEMED Strategic Research and Innovation Agenda (BLUEMED SRIA) provides the tool for all public and private stakeholders involved in the development of the BLUEMED Initiative. The BLUEMED SRIA outlines a set of key challenges for the Mediterranean and particularly knowledge gaps, specific activities enabling the blue growth as well as measures for capacity creation and skills’ enhancement.
Public dialogue with concerned national stakeholders is essential for implementing the objectives of the BLUEMED Initiative and in particular for the monitoring and the update process of the SRIA. As a tool to ensure constant consultation, four thematic Platforms at Mediterranean level will be created.
National Pivots are key contributors to Platform operation, representatives of the different partner countries on the four specific platform themes. NPs can be members of national public administrations, research institutions or stakeholders and preferably should come from organizations outside the partnership of the BLUEMED CSA. Read More
The GSO BLUEMED Working Group, established in the framework of Euro-Mediterranean Senior Officials Group in Research and Innovation, is the steering body of the BLUEMED Initiative. Co-chaired by the two chairs of the Union for the Mediterranean, EC-DG Research and Innovation and Jordan , in close cooperation with the Secretariat of the Union for the Mediterranean (UfMS) and joined by officially appointed delegates from Mediterranean countries, it replaces the role of the Strategic Board.
The BLUEMED CSA consortium is composed of partners from Cyprus, Croatia, France, Greece, Italy, Malta, Portugal, Slovenia and Spain. Partners represent Research Organizations, Research Funding Agencies and Ministries. The involvement of Funding Agencies and Research Organizations with experience in supporting and/or interfacing with different stakeholders, including policy-makers, private companies and civil society, is a fundamental spur for the implementation of the project’s activities in the framework of the BLUEMED Initiative.